Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor γ, controls hepatitis B virus replication

Virology

Volumn 409, Issue 2, 2011, Pages 290-298

  Yoon, Sarah ^a   Jung, Jaesung ^a   Kim, Taeyeung ^a   Park, Sun ^a   Chwae, Yong Joon ^a   Shin, Ho Joon ^a   Kim, Kyongmin ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adiponectin; Hepatitis B virus replication; PPAR

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID SYNTHASE; HEPATITIS B VIRUS X PROTEIN; LAMIVUDINE; LIVER X RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ADIPOGENESIS; ARTICLE; CELL MUTANT; CELL STRAIN HEPG2; CELLS AND CELL COMPONENTS; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; LIPOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIRUS REPLICATION;

ADIPONECTIN; ANTIVIRAL AGENTS; CELL LINE; GENE EXPRESSION PROFILING; GENE SILENCING; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LAMIVUDINE; PPAR GAMMA; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 78650279970     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.024     Document Type: Article

References (41)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
2. Baranowski M. Biological role of liver X receptor. J. Physiol. Pharmacol. 2008, 59(Suppl 7):31-55.
3. Bouchard M.J., Wang L.H., Schneider R.J. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001, 294:2376-2378.
4. Eberlé D., Hegarty B., Bossard P., Ferré P., Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004, 86:839-848.
5. Funahashi T., Nakamura T., Shimomura I., Maeda K., Kuriyama H., Takahashi M., Arita Y., Kihara S., Matsuzawa Y. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 1999, 38:202-206.
6. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 2003, 278:34268-34276.
7. Gordon A., McLean C.A., Pedersen J.S., Bailey M.J., Roberts S.K. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J. Hepatol. 2005, 43:38-44.
8. Hajjou M., Norel R., Carver R., Marion P., Cullen J., Rogler L.E., Rogler C.E. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J. Med. Virol. 2005, 77:57-65.
9. Hong S.H., Cho O., Kim K., Shin H.J., Kotenko S.V., Park S. Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res. 2007, 126:245-249.
10. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
11. Hu J., Boyer M. Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro. J. Virol. 2006, 80:2141-2150.
12. Hu J., Flores D., Toft D., Wang X., Nguyen D. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 2004, 78:13122-13131.
13. Hui C.-K., Zhang H.-Y., Lee N.P., Chan W., Yueng Y.-H., Leung K.-W., Lu L., Leung N., Lo C.-M., Fan S.-T., Luk J.M., Xu A., Lam K.S., Kwong Y.-L., Lau G.K.K. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J. Hepatol. 2007, 47:191-202.
14. Kim H.Y., Park G.S., Kim E.G., Kang S.H., Shin H.J., Park S., Kim K.H. Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle. Virology 2004, 322:22-30.
15. Kim K., Kim K.H., Kim H.H., Cheong J. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRα Biochem. J. 2008, 416:219-230.
16. Kim K.H., Shin H.-J., Kim K., Choi H.M., Rhee S.H., Moon H.-B., Kim H.H., Yang U.S., Yu D.-Y., Cheong J. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARγ Gastroenterology 2007, 132:1955-1967.
17. Kim S., Kim H.Y., Lee S., Kim S.W., Sohn S., Kim K., Cho H. Hepatitis B virus X protein induces perinuclear mitochondrial clustering in microtubule- and dynein-dependent manners. J. Virol. 2007, 81:1714-1726.
18. Koschel M., Oed D., Gerelsaikhan T., Thomssen R., Bruss V. Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J. Virol. 2000, 74:1-7.
19. Lok A.S. Chronic hepatitis B. N Engl J. Med. 2002, 346:1682-1683.
20. Lu J.-Y., Chuang L.-M., Yang W.-S., Tai T.-Y., Lai M.-Y., Chen P.-J., Kao J.-H., Lee C.-Z., Lee H.-S. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Liver Int. 2005, 25:752-759.
21. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2004, 24:29-33.
22. Melegari M., Wolf S.K., Schneider R.J. Hepatitis B Virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J. Virol. 2005, 79:9810-9820.
23. Na T.-Y., Shin Y.K., Roh K.J., Kang S.-A., Hong I., Oh S.J., Seong J.K., Park C.K., Choi Y.L., Lee M.-O. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2009, 49:1122-1131.
24. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
25. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
26. Powell E.E., Jonsson J.R., Clouston A.D. Steatosis: co-factor in other liver diseases. Hepatology 2005, 42:5-13.
27. Schadinger S.E., Bucher N.L., Schreiber B.M., Farmer S.R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1195-E1205.
28. Sells M.A., Chen M.-L., Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl Acad. Sci. USA 1987, 84:1005-1009.
29. Sheikh M.Y., Choi J., Qadri I., Friedman J.E., Sanyal A.J. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008, 47:2127-2133.
30. Tietge U.J., Böker K.H., Manns M.P., Bahr M.J. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E82-E89.
31. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8:1224-1234.
32. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
33. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77:289-312.
34. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., Staiger H., Maerker E., Häring H., Stumvoll M. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52:239-243.
35. Wakui Y., Inoue J., Ueno Y., Fukushima K., Kondo Y., Kakazu E., Obara N., Kimiura O., Shimosegawa T. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-γ ligand, rosiglitazone. Biochem. Biophys. Res. Comm. 2010, 396:508-514.
36. Wong V.W., Wong G.L., Yu J., Choi P.C., Chan A.W., Chan H.-Y., Chu E.S., Cheng A.S., Chim A.M., Chan F.K., Sung J.J., Chan H.L. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Am. J. Gastroenterol. 2010, 105:132-138.
37. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
38. Yang F., Yan S., He Y., Wang F., Song S., Guol Y., Zhou Q., Wang Y., Lin Z., Yang Y., Zhang W., Sun S. Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J. Hepatol. 2008, 48:12-19.
39. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A.J., Tomiyama Y., Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
40. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 2003, 278:498-505.
41. Zhou J., Febbraio M., Wada T., Zhai Y., Kuruba R., He J., Lee J.H., Khadem S., Ren S., Li S., Silverstein R.L., Xie W. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008, 134:556-567.